These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29442075)

  • 21. Testosterone and cardiovascular risk in men.
    Kelly DM; Jones TH
    Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition.
    Bühler FR
    J Hypertens Suppl; 1997 Dec; 15(5):S3-7. PubMed ID: 9481610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens and cardiovascular disease.
    Liu PY; Death AK; Handelsman DJ
    Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism.
    Miller KK; Biller BM; Schaub A; Pulaski-Liebert K; Bradwin G; Rifai N; Klibanski A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2474-9. PubMed ID: 17426086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormones and cardiovascular disease in older men.
    Yeap BB; Flicker L
    J Am Med Dir Assoc; 2014 May; 15(5):326-33. PubMed ID: 24529874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of androgens on lipids.
    Monroe AK; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
    Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgens and coronary artery disease.
    Wu FC; von Eckardstein A
    Endocr Rev; 2003 Apr; 24(2):183-217. PubMed ID: 12700179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone, cardiovascular disease and the metabolic syndrome.
    Corona G; Rastrelli G; Vignozzi L; Mannucci E; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):337-53. PubMed ID: 21397202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone therapy and cardiovascular risk: advances and controversies.
    Morgentaler A; Miner MM; Caliber M; Guay AT; Khera M; Traish AM
    Mayo Clin Proc; 2015 Feb; 90(2):224-51. PubMed ID: 25636998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone and heart failure.
    Volterrani M; Rosano G; Iellamo F
    Endocrine; 2012 Oct; 42(2):272-7. PubMed ID: 22729951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials.
    Zhang KS; Zhao MJ; An Q; Jia YF; Fu LL; Xu JF; Gu YQ
    Andrology; 2018 Jan; 6(1):37-46. PubMed ID: 28950433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.
    Singh AB; Hsia S; Alaupovic P; Sinha-Hikim I; Woodhouse L; Buchanan TA; Shen R; Bross R; Berman N; Bhasin S
    J Clin Endocrinol Metab; 2002 Jan; 87(1):136-43. PubMed ID: 11788637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.